Anita M van den Hoek Selected Research

Drug Therapy (Chemotherapy)

11/2021

Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anita M van den Hoek Research Topics

Disease

14	Inflammation (Inflammations) 05/2023 - 01/2012
11	Insulin Resistance 01/2021 - 01/2004
10	Fibrosis (Cirrhosis) 05/2023 - 11/2015
8	Atherosclerosis 05/2023 - 01/2010
7	Obesity 05/2023 - 01/2011
6	Body Weight (Weight, Body) 03/2023 - 01/2004
6	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2011
5	Alcoholic Fatty Liver 05/2023 - 11/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023 - 01/2012
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 03/2014
3	Non-alcoholic Fatty Liver Disease 04/2023 - 01/2013
3	Fatty Liver 11/2021 - 05/2014
3	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2019
3	Weight Gain 11/2015 - 05/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 01/2017
2	Hypertrophy 02/2020 - 05/2014
2	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 10/2004
2	Weight Loss (Weight Reduction) 12/2014 - 01/2012
2	Hypertension (High Blood Pressure) 01/2012 - 01/2011
2	Hypercholesterolemia 01/2012 - 01/2011
1	Weight Cycling 04/2024
1	Malnutrition (Nutritional Deficiencies) 06/2023
1	Sarcopenia 06/2023
1	Liver Diseases (Liver Disease) 11/2021
1	Frailty 01/2020
1	Diabetes Complications 01/2019
1	Muscular Atrophy (Muscle Atrophy) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Glucose Intolerance 05/2015
1	Hyperglycemia 05/2013
1	Overweight 01/2011
1	Skin Abnormalities 01/2004

Drug/Important Bio-Agent (IBA)

10	Apolipoproteins E (ApoE)IBA 04/2023 - 01/2010
10	CholesterolIBA 04/2023 - 01/2004
9	LipidsIBA 11/2021 - 01/2011
9	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 01/2004
7	Insulin (Novolin)FDA Link 04/2024 - 01/2004
3	Nonesterified Fatty Acids (NEFA)IBA 04/2024 - 01/2004
3	Atorvastatin (Lipitor)FDA Link 04/2023 - 01/2012
3	Triglycerides (Triacylglycerol)IBA 05/2015 - 01/2004
2	Blood Glucose (Blood Sugar)IBA 04/2024 - 05/2013
2	Alanine Transaminase (SGPT)IBA 04/2024 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 02/2020
2	obeticholic acidIBA 11/2020 - 12/2018
2	Eicosapentaenoic AcidIBA 11/2020 - 02/2020
2	icosabutateIBA 11/2020 - 02/2020
2	Rosiglitazone (Avandia)FDA Link 02/2020 - 01/2004
2	salicylsalicylic acid (salsalate)IBA 11/2015 - 05/2015
2	RimonabantIBA 01/2012 - 01/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2007 - 01/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 05/2023
1	semaglutideIBA 05/2023
1	InflammasomesIBA 04/2023
1	Branched-Chain Amino AcidsIBA 03/2023
1	lathosterol delta-5-dehydrogenase (lathosterol oxidase)IBA 07/2022
1	2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 11/2020
1	Islet Amyloid PolypeptideIBA 11/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020
1	FructoseIBA 11/2020
1	Pioglitazone (Actos)FDA Link 02/2020
1	Fenofibrate (CiL)FDA LinkGeneric 02/2020
1	acylcarnitineIBA 01/2020
1	GlucokinaseIBA 01/2019
1	CollagenIBA 12/2018
1	propagermanium (Ge 132)IBA 01/2017
1	CannabinoidsIBA 12/2014
1	alirocumabIBA 10/2014
1	Peroxidase (Myeloperoxidase)IBA 05/2014
1	InterleukinsIBA 05/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2014
1	CarbohydratesIBA 05/2014
1	LipopolysaccharidesIBA 05/2014
1	Transcription Factors (Transcription Factor)IBA 05/2014
1	Metformin (Glucophage)FDA LinkGeneric 03/2014
1	cholebine (colestilan)IBA 05/2013
1	Bile Acids and Salts (Bile Acids)IBA 05/2013
1	C 39 (C39)IBA 01/2012
1	SUB885CIBA 01/2012
1	aliskiren FDA Link 01/2012
1	Renin InhibitorsIBA 01/2012
1	Apolipoprotein E3IBA 01/2011
1	Cholesterol Ester Transfer ProteinsIBA 01/2011
1	CNTO 530IBA 01/2011
1	low density lipoprotein inhibitorIBA 01/2010
1	Neuropeptide YIBA 09/2008
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 08/2004
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 01/2004

Therapy/Procedure

2	Caloric Restriction 06/2023 - 01/2019
2	Therapeutics 11/2021 - 01/2018
1	Drug Therapy (Chemotherapy) 11/2021